Hepatic fat accumulation and regulation of FAT/CD36: An effect of hepatic irradiation

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 8, 2014, Pages 5379-5392

  Martius, Gesa ^a   Alwahsh, Salamah Mohammad ^a   Rave Fra¨nk, Margret ^a   Hess, Clemens Friedrich ^a   Christiansen, Hans ^a,b   Ramadori, Giuliano ^a   Malik, Ihtzaz Ahmed ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cytokines; Fat accumulation; FAT CD36; Inflammation; Liver; Radiation

Indexed keywords

CD36 ANTIGEN;

ADVERSE EFFECTS; ANIMAL; DISEASE MODEL; FATTY LIVER; GENE EXPRESSION REGULATION; HUMAN; LIPID METABOLISM; LIVER; MALE; METABOLISM; RADIATION RESPONSE; RADIOTHERAPY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; U937 CELL LINE; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; ANTIGENS, CD36; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; LIVER; MALE; RADIOTHERAPY; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; U937 CELLS;

EID: 84907148393     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD and Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1343-1351.
2. Tilg H and Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010; 52: 1836-1846.
3. Silverstein RL and Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2009; 2: re3.
4. Storch J and Thumser AE. The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 2000; 1486: 28-44.
5. Zhang X, Fitzsimmons RL, Cleland LG, Ey PL, Zannettino AC, Farmer EA, Sincock P and Mayrhofer G. CD36/fatty acid translocase in rats: distribution, isolation from hepatocytes, and comparison with the scavenger receptor SR-B1. Lab Invest 2003; 83: 317-332.
6. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL and Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 2000; 275: 32523-32529.
7. Zhou J, Febbraio M, Wada T, Zhai Y, Kuruba R, He J, Lee JH, Khadem S, Ren S, Li S, Silverstein RL and Xie W. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology 2008; 134: 556-567.
8. Yang J, Sambandam N, Han X, Gross RW, Courtois M, Kovacs A, Febbraio M, Finck BN and Kelly DP. CD36 deficiency rescues lipotoxic cardiomyopathy. Circ Res 2007; 100: 1208-1217.
9. Dyck JR, Berthiaume LG, Thomas PD, Kantor PF, Barr AJ, Barr R, Singh D, Hopkins TA, Voilley N, Prentki M and Lopaschuk GD. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism. Biochem J 2000; 350: 599-608.
10. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC and Mitchell JB. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010; 15: 360-371.
11. Shim SJ, Seong J, Lee IJ, Han KH, Chon CY and Ahn SH. Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma. Hepatol Res 2007; 37: 906-913.
12. Christiansen H, Sheikh N, Saile B, Reuter F, Rave-Frank M, Hermann RM, Dudas J, Hille A, Hess CF and Ramadori G. X-Irradiation in rat liver: consequent upregulation of hepcidin and downregulation of hemojuvelin and ferroportin-1 gene expression. Radiology 2007; 242: 189-197.
13. Jo SK, Seol MA, Park HR, Jung U and Roh C. Ionising radiation triggers fat accumulation in white adipose tissue. Int J Radiat Biol 2011; 87: 302-310.
14. Malik IA, Moriconi F, Sheikh N, Naz N, Khan S, Dudas J, Mansuroglu T, Hess CF, Rave-Frank M, Christiansen H and Ramadori G. Single-dose gamma-irradiation induces up-regulation of chemokine gene expression and recruitment of granulocytes into the portal area but not into other regions of rat hepatic tissue. Am J Pathol 2010; 176: 1801-1815.
15. Christiansen H, Batusic D, Saile B, Hermann RM, Dudas J, Rave-Frank M, Hess CF, Schmidberger H and Ramadori G. Identification of genes responsive to gamma radiation in rat hepatocytes and rat liver by cDNA array gene expression analysis. Radiat Res 2006; 165: 318-325.
16. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
17. Naz N, Moriconi F, Ahmad S, Amanzada A, Khan S, Mihm S, Ramadori G and Malik IA. Ferritin L is the sole serum ferritin constituent and a positive hepatic acute-phase protein. Shock 2013; 39: 520-526.
18. Ahmad S, Moriconi F, Naz N, Sultan S, Sheikh N, Ramadori G and Malik IA. Ferritin L and Ferritin H are differentially located within hepatic and extra hepatic organs under physiological and acute phase conditions. Int J Clin Exp Pathol 2013; 6: 622-629.
19. Amanzada A, Moriconi F, Mansuroglu T, Cameron S, Ramadori G and Malik A. Induction of chemokines and cytokines before neutrophils and macrophage recruitment in different regions of rat liver after TAA administration. Lab Invest 2014; 94: 235-47.
20. Lauzier B, Merlen C, Vaillant F, McDuff J, Bouchard B, Beguin PC, Dolinsky VW, Foisy S, Villeneuve LR, Labarthe F, Dyck JR, Allen BG, Charron G and Des RC. Post-translational modifications, a key process in CD36 function: lessons from the spontaneously hypertensive rat heart. J Mol Cell Cardiol 2011; 51: 99-108.
21. DiDonato JA, Mercurio F and Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev 2012; 246: 379-400.
22. Gruarin P, Sitia R and Alessio M. Formation of one or more intrachain disulphide bonds is required for the intracellular processing and transport of CD36. Biochem J 1997; 328: 635-642.
23. Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M and Ten Haken RK. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 2010; 76: S94-100.
24. Tiniakos DG, Vos MB and Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010; 5: 145-171.
25. Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Scholmerich J and Bollheimer LC. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 2006; 36: 485-501.
26. Nguyen P, Leray V, Diez M, Serisier S, Le BJ, Siliart B and Dumon H. Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl) 2008; 92: 272-283.
27. Abu-Elheiga L, Wu H, Gu Z, Bressler R and Wakil SJ. Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions. J Biol Chem 2012; 287: 12578-12588.
28. Degrace P, Moindrot B, Mohamed I, Gresti J, Du ZY, Chardigny JM, Sebedio JL and Clouet P. Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid. J Lipid Res 2006; 47: 2647-2655.
29. Grefhorst A, Elzinga BM, Voshol PJ, Plosch T, Kok T, Bloks VW, van der Sluijs FH, Havekes LM, Romijn JA, Verkade HJ and Kuipers F. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem 2002; 277: 34182-34190.
30. Motojima K, Passilly P, Peters JM, Gonzalez FJ and Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 1998; 273: 16710-16714.
31. Oyama Y, Takeda T, Hama H, Tanuma A, Iino N, Sato K, Kaseda R, Ma M, Yamamoto T, Fujii H, Kazama JJ, Odani S, Terada Y, Mizuta K, Gejyo F and Saito A. Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules. Lab Invest 2005; 85: 522-531.
32. Coe NR and Bernlohr DA. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta 1998; 1391: 287-306.
33. Koonen DP, Jacobs RL, Febbraio M, Young ME, Soltys CL, Ong H, Vance DE and Dyck JR. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 2007; 56: 2863-2871.
34. Gupta D, Arora R, Garg AP, Bala M and Goel HC. Modification of radiation damage to mitochondrial system in vivo by Podophyllum hexandrum: mechanistic aspects. Mol Cell Biochem 2004; 266: 65-77.
35. Perez-Carreras M, Del HP, Martin MA, Rubio JC, Martin A, Castellano G, Colina F, Arenas J and Solis-Herruzo JA. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003; 38: 999-1007.
36. Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW and Ibdah JA. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 2010; 52: 727-736.
37. Akkaoui M, Cohen I, Esnous C, Lenoir V, Sournac M, Girard J and Prip-Buus C. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids. Biochem J 2009; 420: 429-438.
38. Bruce CR, Hoy AJ, Turner N, Watt MJ, Allen TL, Carpenter K, Cooney GJ, Febbraio MA andKraegen EW. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 2009; 58: 550-558.
39. Jambor de Sousa UL, Koss MD, Fillies M, Gahl A, Scheeder MR, Cardoso MC, Leonhardt H, Geary N, Langhans W and Leonhardt M. CPT1alpha over-expression increases long-chain fatty acid oxidation and reduces cell viability with incremental palmitic acid concentration in 293T cells. Biochem Biophys Res Commun 2005; 338: 757-761.
40. Reddy JK and Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 2006; 290: G852-G858.
41. Karin M and Gallagher E. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes. Immunol Rev 2009; 228: 225-240.
42. Takahashi Y, Soejima Y and Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18: 2300-2308.
43. Alwahsh SM, Xu M, Schultze FC, Wilting J, Mihm S, Raddatz D, Ramadori G. Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats. PLoS One 2014; 9: e104220.
44. Alwahsh SM, Xu M, Seyhan HA, Ahmad S, Mihm S, Ramadori G, Schultze FC. Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver. World J Gastroenterol 2014; 20: 1807-21.